News
On Thursday, 11 December 2025, Karl Landsteiner University hosted the inaugural lecture of Prof. Victor Zevallos. In his lecture entitled ‘Plant Proteins, the Immune System and the Microbiome: From the Andes to the World’, Professor Zevallos highlighted current scientific findings on the role of plant-based food components in immunological and inflammatory diseases of the gastrointestinal tract.
Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development.
On October 21, after a preselection phase, the first Candidate Hearing took place at the Karl Landsteiner University in Krems.
The research groups of Gerald Obermair (Department of Physiology), Dagmar Stoiber-Sakaguchi (Department of Pharmacology) and Klaus Podar (Department of Molecular Oncology and Hematology) have been awarded the ‘Green Lab Austria’ label for their commitment to establishing and managing sustainable laboratory operations.
The inaugural lectures of Prof. Dr. Piero Fossati MD, Professor of Radiation Oncology, and Prof. PD DI Markus Stock PhD, Professor of Medical Physics, took place on 6 November 2024 in the KL Krems auditorium under the title "Particle therapy - maximising precision in cancer therapy: medical physics and radiooncology discourse".
Wie läuft eigentlich das Studium an der KL ab?
Im Rahmen von Uniluft schnuppern haben interessierte Schüler:innen die Möglichkeit direkt in eine Vorlesung an der KL reinzuschnuppern. Wir haben dafür exklusive Vorlesungen ausgewählt, bei denen zukünftige Bewerber:innen den Unterricht vor Ort in Krems an der KL miterleben können.
Am 9. Oktober fand an der Karl Landsteiner Universität in Krems eine besondere Typisierungsaktion statt, bei der 265 engagierte Studierende als neue Stammzellspender:innen in die weltweite Spenderdatenbank aufgenommen werden konnten.
Karl Landsteiner Privatuniversität für Gesundheitswissenschaften (KL Krems) startet gemeinsam mit zentralen Partnerinnen und Partnern aus Bildung, Medizin und Humanitärer Hilfe ein Trainingsprogramm für Reanimation und Erste Hilfe.
The simultaneous inhibition of the transcription factors Myc and JunB could represent a pioneering therapeutic option for the treatment of multiple myeloma (MM), the second most common type of blood cancer.
Rudolf Valenta, allergologist at MedUni Vienna and programme manager of the Danube Allergy Research Cluster (Danube ARC) at the Karl Landsteiner University of Health Sciences (KL Krems), was honoured by the German Society for Clinical Chemistry and Laboratory Medicine with the prestigious prize for biochemical analysis. The prize recognises outstanding scientific achievements in the field of biochemical and molecular analysis.
The prestigious Science Awards of the State of Lower Austria were presented at the Wissenschaftsgala 2024 in the Moonstone Building at the Institute of Science and Technology Austria (ISTA) on Wednesday, 9 October 2024. Two researchers from Karl Landsteiner University of Health Sciences (KL Krems) were honoured for their outstanding scientific contributions.
A groundbreaking success in the fight against hepatitis C: As part of the cross-institutional ELIMINATE project, hospital data was systematically analyzed in ten hospitals in Vienna (including 6 WIGEV clinics) and Lower Austria in order to identify and treat those affected. As a result, almost 400 patients were cured of their chronic hepatitis C disease using modern therapies.